Improving Sleep to Prevent Depression & Anxiety in Adolescents at High Risk
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-18
SponsorUniversity of Calgary
About this trial
Emerging evidence has shown that sleep interventions such as Cognitive Behavioral Therapy for Insomnia (CBT-I) improve depressive and anxiety symptoms in adults, even when the intervention is brief, such as four to six sessions. The overarching aim of the proposed research is to conduct a pilot trial to evaluate whether a brief intervention for insomnia adapted for improves sleep and subthreshold depressive and anxiety symptoms in adolescents at risk (i.e., with a parental history of depressive or anxiety disorders).
Eligibility criteria
Qualifiers
Between the ages of 12 and 18.
Having at least one parent with a history of depressive or anxiety disorders but having no clinically significant history (per the Diagnostic and Statistical Manual of Mental Disorders 5) of internalizing disorders themselves.
Adolescents who score 10/25 or greater on the Insomnia Severity Index, indicating subthreshold insomnia or greater.
Disqualifiers
Experiencing symptoms of sleep disorders other than insomnia (i.e. restless legs syndrome [RLS], sleep-disordered breathing [SDB].
Having a history of untreated, serious psychiatric illness (i.e., bipolar disorder, schizophrenia).
Active suicidal ideation.
Currently taking prescribed medications for sleep problems.
Trial design
Treatments tested in this trial
- Cognitive Behavioral Therapy for Insomnia
- Active Control
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Calgary
Lead sponsor
Hotchkiss Brain Institute, University of Calgary
Collaborator
Source ClinicalTrials.gov